- Over the last year, the use of and interest in glucagon-like peptide-1 (GLP-1) receptor agonists has significantly increased.
- Scientists have been examining the use of the GLP-1 drug liraglutide to treat additional treatments other than type 2 diabetes and obesity.
- Researchers from Imperial College London have found that liraglutide may also help…
Read the full article here